Robert W. Comer
Keine laufenden Positionen mehr
Profil
Robert W.
Comer has served as a Director of Hemobiotech, Inc. since April 6, 2005 and serves as Chairman of the Audit Committee and as a Member of the Nominating and Corporate Governance Committee.
Previously, he served as Acting Chief Financial Officer of Hemobiotech from November 18, 2004 to April 1, 2005.
From 1991 to 1994, Mr. Comer served as Chief Financial Officer of Banc One Management and Consulting Corporation.
From 1987 to 1991, he was Managing Partner of Robert W.
Comer & Associates.
Previously, he was a Director of Financial Management Services of InterFirst Corporation from 1985 to 1987 and an Audit Partner with Arthur Andersen & Co. from 1969 to 1981.
Mr. Comer received a BS and an MBA from Indiana University.
Robert Comer has served as a director since April 6, 2005.
Mr. Comer currently serves as Chairman of the Audit Committee and is a member of the Nominating and Corporate Governance Committee.
From 1994 to the present, Mr. Comer has been involved in contract consulting and served as our Acting Chief Financial Officer between November 18, 2004 and April 1, 2005.
From 1991 to 1994, he served as Chief Financial Officer of Banc One Management and Consulting Corporation.
From 1987 to 1991, Mr. Comer was Managing Partner of Robert W.
Comer & Associates.
From 1985 to 1987, Mr. Comer was a Director of Financial Management Services of InterFirst Corporation.
From 1969 to 1981, Mr. Comer was an audit partner with Arthur Andersen & Co. Mr. Comer received his B.S.
and M.B.A.
degrees from Indiana University.
Ehemalige bekannte Positionen von Robert W. Comer
Unternehmen | Position | Ende |
---|---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Finanzdirektor/CFO | - |
Ausbildung von Robert W. Comer
Indiana University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |